Top in endocrinology: Cannabis and menopause, undiagnosed diabetes
A recent survey revealed that cannabis use is a common approach for treating menopause symptoms. It was the top story in endocrinology last week.
Another top story was about the prevalence of undiagnosed diabetes in a large cohort of adults in the United Kingdom.
Read these and more top stories in endocrinology below:
Cannabis use ‘common’ approach to treating menopause symptoms
More than one-quarter of a group of midlife women who receive care through the Department of Veterans Affairs in Northern California are using cannabis to treat menopause symptoms, according to survey results. Read more.
HbA1c screening reveals 1% may have undiagnosed diabetes
Using HbA1c testing to screen adults from a large U.K. database revealed approximately 1% had undiagnosed diabetes that was measurable on average 2 years before diagnosis by a health care provider, study data show. Read more.
‘Evidence of synergy’: Short sleep, hot flashes associated with CV risk in menopause
Frequent hot flashes are associated with indicators of cardiovascular disease among midlife and older women; poor sleep and trauma history may act synergistically with vasomotor symptoms to further increase risk, according to a speaker from the North American Menopause Society. Read more.
HT reduces inflammation biomarkers for women in early menopause
A 1 mg dose of estradiol reduced biomarkers of inflammation tied to atherosclerosis in postmenopausal women — particularly those in early menopause — participating in the Early vs. Late Intervention Trial with Estradiol. Read more.
CVD, stroke risks increase with number of menopause symptoms
Women who reported two or more moderate to severe menopause symptoms had increased risks for cardiovascular disease and stroke, but vasomotor symptom severity did not affect risk, according to data from the WHI Calcium and Vitamin D trial. Read more.